Christopher Von Seggern Xenon Pharmaceuticals Inc. (XENE) insider trading activity
Christopher Von Seggern is Chief Commercial Officer of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 4,000 shares of XENE, which is worth approximately $164,440. The most recent transaction as insider was on Dec 06, 2021, when has been sold 4,000 shares (Common Shares) at a price of $24.4 per share, resulting in proceeds of $97,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4K
0%
3M change
0%
12M change
Total Value Held
$164,440
CVS
Christopher Von Seggern
Chief Commercial Officer
Burnaby, A1